However, a study that analysed the synaptosomal expression of NCX3 in the parietal cortex of late-stage AD patients revealed that NCX3 co-localized with Aβ in synaptic terminals and was up-regulated in pathological terminals that contained Aβ [59]. This evidence concerns the gene SLC8A3 and Alzheimer disease.